Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Dr. Reddy's Laboratories Share Price Shows Minor Increase in Recent Trading

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Dr. Reddy's Laboratories Share Price Shows Minor Increase in Recent Trading

Analysed 17 Nov 2026·2 sources analysed·Business
Dr. Reddy's Laboratories Share Price Shows Minor Increase in Recent TradingPreviousNext

Dr. Reddy's Laboratories' share price showed a slight increase, trading at 1379.4 INR on November 17, 2026, compared to a closing price of 1374.9 INR on November 16. Market capitalization ranged around 114,700 to 115,250 crore INR, with price-to-earnings ratios near 41 and earnings per share steady at 33.54. Trading volumes varied between approximately 241,000 and 922,000 shares. These updates reflect ongoing market activity and expert analysis of the stock's performance.

Sentiment
50%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 28/100.

Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 17 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (50/100)

Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

economictimes broke this story on 16 Nov, 10:46 am. Other outlets followed.

16 Nov, 10:46 am2 sources · 19 h17 Nov, 05:54 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Eicher Motors Stock Shows Positive Movement with Updated Market Data
Next →
How Home and Personal Loan Interest Rates Affect Total Repayment Costs
1
economictimes16 Nov, 10:46 am
Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories reports a closing price of Rs 1374.9
  • 2
    economictimes17 Nov, 05:54 am
    Dr Reddys Share Price Live Updates: Dr. Reddys experiences a minor uptick in share price
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Dr. Reddy's LaboratoriesDr Reddys Laboratories Limited

    Story context

    Category
    Business
    Sources analysed
    2
    Last analysed
    17 Nov 2026
    Key entities
    Reddi KingdomEarnings per shareMarket capitalizationPrice–earnings ratioShare priceAmplitude modulationDr. Reddy's LaboratoriesIndian rupeeStock